基于人群的队列研究中内镜后食管腺癌与内镜后食管肿瘤的规模及时间趋势:北欧巴雷特食管研究
该研究在丹麦、芬兰和瑞典纳入2006至2020年新诊断巴雷特食管的20588例患者,评估内镜后食管腺癌(PEEC)和内镜后食管肿瘤(PEEN)的规模及时间趋势。结果显示23.5%的食管腺癌为PEEC,PEEC发病率为392/10万人年,且PEEC/PEEN发病率呈上升趋势。
要点
- 新诊断巴雷特食管患者中,23.5%的食管腺癌为内镜后食管腺癌(PEEC)。
- PEEC发病率为392/10万人年,PEEN发病率为421/10万人年。
- 时间趋势分析显示PEEC/PEEN发病率呈上升趋势。
核心结论
- 在新诊断巴雷特食管患者中,近四分之一的食管腺癌在表面上阴性上消化道内镜后一年内被检出。
研究设计与样本
- 这项基于人群的队列研究在丹麦、芬兰和瑞典开展,纳入2006年至2020年新诊断巴雷特食管的20588例患者。
- PEEC定义为巴雷特食管诊断(指数内镜)后30至365天诊断的食管腺癌,PEEN定义为同期诊断的高级别上皮内瘤变/食管腺癌。
- 患者随访至高级别上皮内瘤变/食管腺癌、死亡或研究期结束。
主要发现
- 在293例诊断为食管腺癌的患者中,69例(23.5%)为PEEC,43例(14.7%)为指数食管腺癌,181例(61.8%)为偶发食管腺癌。
- PEEC发病率为392/10万人年(95%CI,309-496),偶发食管腺癌发病率为208/10万人年(95%CI,180-241)。
- 在279例诊断为高级别上皮内瘤变/食管腺癌的患者(仅瑞典)中,17.2%为PEEN,14.6%为指数高级别上皮内瘤变/食管腺癌,68.1%为偶发高级别上皮内瘤变/食管腺癌。
- PEEN发病率为421/10万人年(95%CI,317-558),偶发高级别上皮内瘤变/食管腺癌发病率为285/10万人年(95%CI,247-328)。
- 改变PEEC/PEEN发生时间区间的敏感性分析显示相似结果;发病率的时间趋势分析显示PEEC/PEEN发病率上升。
临床怎么用
- 作者认为,提高检出率的干预措施可能降低PEEC/PEEN发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Post-endoscopy esophageal adenocarcinoma (PEEC) and post-endoscopy esophageal neoplasia (PEEN) undermine early cancer detection in Barrett's esophagus (BE). We aimed to assess the magnitude and conduct time-trend analysis of PEEC and PEEN among patients with newly diagnosed BE. METHODS: This population-based cohort study was conducted in Denmark, Finland, and Sweden between 2006 and 2020 and included 20,588 patients with newly diagnosed BE. PEEC and PEEN were defined as esophageal adenocarcinoma (EAC) or high-grade dysplasia (HGD)/EAC, respectively, diagnosed 30-365 days from BE diagnosis (index endoscopy). HGD/EAC diagnosed from 0-29 days and HGD/EAC diagnosed >365 days from BE diagnosis (incident HGD/EAC) were assessed. Patients were followed up until HGD/EAC, death, or end of study period. Incidence rates (IR) per 100,000 person-years with 95% confidence interval (95% CI) were calculated using Poisson regression. RESULTS: Among 293 patients diagnosed with EAC, 69 (23.5%) were categorized as PEEC, 43 (14.7%) as index EAC, and 181 (61.8%) as incident EAC. The IRs/100,000 person-years for PEEC and incident EAC were 392 (95% CI, 309-496), and 208 (95% CI, 180-241), respectively. Among 279 patients diagnosed with HGD/EAC (Sweden only), 17.2% were categorized as PEEN, 14.6% as index HGD/EAC, and 68.1% as incident HGD/EAC. IRs/100,000 person-years for PEEN, and incident HGD/EAC were 421 (95% CI, 317-558), and 285 (95% CI, 247-328), respectively. Sensitivity analyses that varied time interval for occurrence of PEEC/PEEN demonstrated similar results. A time-trend analysis for IRs demonstrated rising incidence rates of PEEC/PEEN. CONCLUSIONS: Almost a quarter of all EACs are detected within a year after an ostensibly negative upper endoscopy in patients with newly diagnosed BE. Interventions to improve detection may reduce PEEC/PEEN rates.
引用
- Wani S, Holmberg D, Santoni G, et al. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study. Gastroenterology. 2023. PMID: 37279832. doi:10.1053/j.gastro.2023.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。